Santhera Pharmaceuticals
Developing innovative medicines
- B2B
About Santhera Pharmaceuticals
Swiss pharmaceutical company focusing on developing innovative treatments for rare neuromuscular and pulmonary diseases, including vamorolone for DMD and lonodelestat for CF
Key facts
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51–250 employees
- Headquarters
- Pratteln, Basel-Country, Switzerland
- Founded
- 2004
- Revenue
- CHF 77.2MFY2025, publicly reported
- Website
- santhera.com
Santhera Pharmaceuticals at a glance
Santhera Pharmaceuticals is a B2B company in the Pharmaceutical Manufacturing industry, headquartered in Pratteln, Basel-Country, Switzerland.
Santhera Pharmaceuticals was founded in 2004.
Santhera Pharmaceuticals has 51–250 employees.
Santhera Pharmaceuticals's revenue is CHF 77.2M (FY2025, publicly reported).
Frequently asked questions about Santhera Pharmaceuticals
What is Santhera Pharmaceuticals's revenue?
Santhera Pharmaceuticals's revenue is CHF 77.2M (FY2025, publicly reported).
How many employees does Santhera Pharmaceuticals have?
Santhera Pharmaceuticals has 51–250 employees.
Where is Santhera Pharmaceuticals headquartered?
Santhera Pharmaceuticals is headquartered in Pratteln, Basel-Country, Switzerland.
Selling to companies like Santhera Pharmaceuticals?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies